The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis

被引：0
|
作者：
Fa Mee Doh
Tae-Ik Chang
Hyang Mo Koo
Mi Jung Lee
Dong Ho Shin
Chan Ho Kim
Kwang Il Ko
Hyung Jung Oh
Tae-Hyun Yoo
Shin-Wook Kang
Dae-Suk Han
Seung Hyeok Han
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] NHIC Ilsan Hospital,Division of Nephrology
[3] Yonsei University,Brain Korea 21 for Medical Science, Severance Biomedical Science Institute
来源：
Cardiovascular Drugs and Therapy | 2012年 / 26卷
关键词：
HMG-CoA reductase inhibitor; Insulin resistance; Peritoneal dialysis; Adipokine; Chronic inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 509
页数：8
相关论文
共 50 条
  • [41] Effect of the HMG-CoA Reductase Inhibitor Rosuvastatin on Early Chronic Kidney Injury in Obese Zucker Rats Fed With an Atherogenic Diet
    Reisin, Efrain
    Ebenezer, Philip J.
    Liao, Jie
    Lee, Benjamin S.
    Larroque, Michelle
    Hu, Xuejiao
    Aguilar, Erwin A.
    Morse, Stephen A.
    Francis, Joseph
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 338 (04) : 301 - 309
  • [42] Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor
    Chapman, BA
    Burt, MJ
    Chisholm, RJ
    Allan, RB
    Yeo, KHJ
    Ross, AG
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (02) : 349 - 353
  • [43] Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors
    Pfefferkorn, Jeffrey A.
    Choi, Chulho
    Song, Yuntao
    Trivedi, Bharat K.
    Larsen, Scott D.
    Askew, Valerie
    Dillon, Lisa
    Hanselman, Jeffrey C.
    Lin, Zhiwu
    Lu, Gina
    Robertson, Andrew
    Sekerke, Catherine
    Auerbach, Bruce
    Pavlovsky, Alexander
    Harris, Melissa S.
    Bainbridge, Graeme
    Caspers, Nicole
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4531 - 4537
  • [44] Dissolution of Gallstones with Simvastatin, an HMG CoA Reductase Inhibitor
    B. A. Chapman
    M. J. Burt
    R. J. Chisholm
    R. B. Allan
    K. H. J. Yeo
    A. G. Ross
    Digestive Diseases and Sciences, 1998, 43 : 349 - 353
  • [45] The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome
    Prescott, WA
    Streetman, DAD
    Streetman, DS
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) : 2105 - 2114
  • [46] Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection
    Sahu, KM
    Sharma, RK
    Gupta, A
    Gulati, S
    Agarwal, DK
    Kumar, A
    Bhandari, M
    CLINICAL TRANSPLANTATION, 2001, 15 (03) : 173 - 175
  • [47] Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis
    Yoon, Chang-Yun
    Lee, Mi Jung
    Kee, Youn Kyung
    Lee, Eunyoung
    Joo, Young Su
    Han, In Mee
    Han, Seung Gyu
    Oh, Hyung Jung
    Park, Jung Tak
    Han, Seung Hyeok
    Kang, Shin-Wook
    Yoo, Tae-Hyun
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2014, 33 (04) : 192 - 198
  • [48] Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients
    Canbakan, Mustafa
    Sahin, Gulizar Manga
    RENAL FAILURE, 2007, 29 (03) : 289 - 293
  • [49] EFFICACY AND SHORT-TERM EFFECTS OF PRAVASTATIN, A POTENT INHIBITOR OF HMG-COA REDUCTASE, ON HYPERCHOLESTEROLEMIA IN CLIMACTERIC WOMEN
    USHIROYAMA, T
    IKEDA, A
    UEKI, M
    SUGIMOTO, O
    JOURNAL OF MEDICINE, 1994, 25 (05) : 319 - 331
  • [50] A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits
    Hayashi, T
    Rani, JA
    Fukatsu, A
    Matsui-Hirai, H
    Osawa, M
    Miyazaki, A
    Tsunekawa, T
    Kano-Hayashi, H
    Iguchi, A
    Sumi, D
    Ignarro, LJ
    ATHEROSCLEROSIS, 2004, 176 (02) : 255 - 263
12345